M&A Merck on Monday announced an agreed $41bn takeover of its New Jersey rival, Schering-Plough , in the second major deal in the global pharmaceuticals industry within six weeks.
The deal, which will create one of the world’s biggest drugmakers with combined sales of nearly $50bn, will be done via a complex reverse takeover in which the much smaller Schering-Plough will technically acquire Merck.
